Prostate cancer patients see longer survival with new combination drug
A new treatment strategy tested by UCLA researchers could offer new hope for men whose prostate cancer has returned after initial treatment.This approach could also help delay the need for hormone therapy, which can have burdensome side effects.The findings, which were presented at the annual American Society for Radiation Oncology (ASTRO) meeting this week, showed that combining a targeted radioactive drug with standard radiation therapy more than doubled the amount […]